Emanuela Felley‐Bosco
Research Interests
Explore related searches
Contact this professor
Articles (11)
The Pattern of RNA Editing Changes in Pleural Mesothelioma upon Epithelial-Mesenchymal Transition
Pleural mesothelioma (PM) is a cancer where epithelioid, biphasic and sarcomatoid histotypes are observed. Sarcomatoid PM is characterized by mesenchymal features. Multi-omics have been used to characterize the epithelial-to-mesenchymal (EMT) phenotype at the molecular level. We contribute to this effort by including the analysis of RNA editing. We extracted samples with the highest vs. lowest Epithelial score from two PM cohorts and observed increased RNA editing in introns and decreased RNA editing in 3′UTR upon EMT. The same was observed in primary PM primary cultures stratified by transcriptomics analysis into two groups, one of them enriched with mesenchymal features. Our data demonstrate that, as has been observed in other cancer types, RNA editing associates to EMT phenotype in PM.
Year:
2023
Heterogeneous <scp>RNA</scp> editing and influence of <scp>ADAR2</scp> on mesothelioma chemoresistance and the tumor microenvironment
We previously observed increased levels of adenosine‐deaminase‐acting‐on‐dsRNA (Adar)‐dependent RNA editing during mesothelioma development in mice exposed to asbestos. The aim of this study was to characterize and assess the role of ADAR‐dependent RNA editing in mesothelioma. We found that tumors and mesothelioma primary cultures have higher ADAR‐mediated RNA editing compared to mesothelial cells. Unsupervised clustering of editing in different genomic regions revealed heterogeneity between tumor samples as well as mesothelioma primary cultures. ADAR2 expression levels are higher in BRCA1‐associated protein 1 wild‐type tumors, with corresponding changes in RNA editing in transcripts and 3'UTR. ADAR2 knockdown and rescue models indicated a role in cell proliferation, altered cell cycle, increased sensitivity to antifolate treatment, and type‐1 interferon signaling upregulation, leading to changes in the microenvironment in vivo . Our data indicate that RNA editing contributes to mesothelioma heterogeneity and highlights an important role of ADAR2 not only in growth regulation in mesothelioma but also in chemotherapy response, in addition to regulating inflammatory response downstream of sensing nucleic acid structures.
Year:
2022
Collaborators (13)
Nadia Mercader
Full Professor
University of Bern
Marc de Perrot
-
Mark Robinson
Professor
University of Zurich
Véronique Serre-Beinier
University Hospital of Geneva
Stefanie Hiltbrunner
University of Fribourg
Michele De Palma
Associate Professor
École Polytechnique Fédérale de Lausanne
Christian Mosimann
The Helen and Arthur E. Johnson Chair for the Cardiac Research Director, Associate Professor of Pediatrics
-
Hubert Rehrauer
-
Stephen Finn
Associate Professor
Trinity College Dublin School of Medicine
Licun Wu
University Health Network
Alessandra Curioni-Fontecedro
Professor of Oncology
University of Fribourg
Kathy Gately
Clinical Senior Lecturer
Trinity College Dublin
Isabelle Opitz
University Hospital of Zurich

How do I reach out?
Sign in for free to see their profile details and contact information.